HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Bronchospasmolytic effectiveness of controlled drug combinations].

Abstract
Two groups of 10 patients each with a chronic obstructive pulmonary disease were the subjects of a comparative study of the effectiveness of 240 mg theophyllinethylendiamine (Euphyllin) and a combined medication consisting of 25 mg theophyllin, 85 mg etophyllin, 30 mg papaverine and 0.1 mg atropine methylnitrate (Perphyllon). Oscillatory resistance (measured with the Siregnost FD 5) and the circulatory parameters pulse and blood pressure were studied. A statistically significant bronchospasmolytic effect was found for both substances administered parenterally. It was shown, however, that the combined medication worked faster, longer and 4 to 5 times more effectively than theophyllinethylendiamine. The possible causes of the differences are discussed. Clinically, the cardiovascular side effects of the combined medication are to be classified as slight. The tested medication has a favorable therapeutic spectrum as a result of the low dosage of the individual substances.
AuthorsG Forche, G Zenker, K Harnoncourt
JournalWiener medizinische Wochenschrift (1946) (Wien Med Wochenschr) Vol. 136 Issue 9 Pg. 213-8 (May 15 1986) ISSN: 0043-5341 [Print] Austria
Vernacular TitleBronchospasmolytische Wirksamkeit kontrollierter Wirkstoffkombinationen.
PMID3739357 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Atropine Derivatives
  • Bronchodilator Agents
  • Drug Combinations
  • Aminophylline
  • perphyllon
  • Theophylline
  • Papaverine
  • Phenobarbital
Topics
  • Airway Resistance (drug effects)
  • Aminophylline (therapeutic use)
  • Atropine Derivatives (therapeutic use)
  • Blood Pressure (drug effects)
  • Bronchial Spasm (drug therapy)
  • Bronchodilator Agents (therapeutic use)
  • Drug Combinations (therapeutic use)
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Infusions, Parenteral
  • Lung Diseases, Obstructive (drug therapy)
  • Male
  • Middle Aged
  • Papaverine (therapeutic use)
  • Phenobarbital (therapeutic use)
  • Theophylline (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: